Verrica Pharmaceuticals Inc.
VRCA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660334
In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Verrica Pharmaceuticals Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 75 | 59 | −16 |
| Shares | 29.5M | 24.9M | −4.58M (−15.5%) |
| Value | $13.0M | $13.4M | +$396.0K (+3.0%) |
New holders (14)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Y-Intercept (Hong Kong) Ltd | 186,955 | $99.1K | 0.00% |
| Marshall Wace, LLP | 123,953 | $65.7K | 0.00% |
| Renaissance Technologies LLC | 87,200 | $46.2K | 0.00% |
| Citadel Advisors LLC | 68,660 | $36.4K | 0.00% |
| Qube Research & Technologies Ltd | 52,955 | $28.1K | 0.00% |
| Jane Street Group, LLC | 38,330 | $20.3K | 0.00% |
| Dynamic Technology Lab Private Ltd | 20,300 | $11.0K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 13,721 | $7.27K | 0.00% |
| Raymond James Financial Inc | 8,400 | $4.45K | 0.00% |
| Cubist Systematic Strategies, LLC | 1,957 | $1.04K | 0.00% |
| Nisa Investment Advisors, LLC | 1,431 | $759 | 0.00% |
| Ameritas Advisory Services, LLC | 300 | $159 | 0.00% |
| Essential Partners LLC | 15 | $8 | 0.00% |
| IFP Advisors, Inc | 6 | $3 | 0.00% |
Sold out (30)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q1 2025 and filed for Q2 2025 without it.